… On the basis of these critical functions of heparin, we illustrate both … heparin therapy has
multiple effects for COVID-19. The therapeutic approach of using heparin to manage COVID-19 …

… that initiation of heparin for 27 patients infected with COVID-19 improved oxygenation; …
COVID-19 have not yet recommended the use of therapeutic heparin or other forms of therapeutic …

… in COVID-19 patients, and heparin use during in-hospital stay has been associated with
decreased mortality. COVID-19 … Interestingly, in COVID-19, pulmonary compliance is preserved …

… We propose that therapeutic treatment with heparin/LMWH will interfere with several
pathological processes in COVID-19 patients, thereby increasing their survival rate. …

… In summary, there are several ways heparin can prove beneficial in patients with COVID‐19
(Figure 1). In this respect, the correct dose of LMWH is a matter of immediate interest as a …

… of COVID-19. Tang et al reported that heparin (particularly low molecular weight heparin) …
In Japan, anticoagulants used for DIC include heparin as well as antithrombin concentrates, …

… therapeutic heparin is beneficial in moderately ill patients but not in severely ill patients
hospitalized with COVID-19… We included RCTs comparing therapeutic-dose heparin …

… the treatment with heparin and mortality in patients admitted with Covid-19. Routinely recorded,
clinical data, up to the 24th of April 2020, from the 2075 patients with Covid-19, admitted …

… among patients with coronavirus disease 2019 (Covid-19). We hypothesized that
therapeutic-dose … may improve outcomes in noncritically ill patients who are hospitalized with …

… sample of patients with COVID-19 hospitalized throughout Italy, shows that heparin use was
… support the use of heparin in in-patients with COVID-19, particularly in severely ill patients. …